OUR 9TH YEAR OF PROVIDING PROPRIETARY CAPITAL MARKETS INTELLIGENCE ON THE CANNABIS / HEMP / PSYCHEDELIC SECTORS
Equity Capital Raises
Equity Transaction Chart
Viridian publishes weekly data on equity capital raises in the Cannabis/CBD/Psychedelic industries. This data includes information about the company issuing equity (public/private, state/country location), deal size, deal structure, pricing, share information, deal implied valuation, and warrant information.
Week ended 11/15/2024
Week ended 11/15/2024
This Section is Only Available to Higher Tier Memberships
Please Purchase a Premium or Enterprise membership to see more.
Equity Commentary
Week ended 11/15/2024
Equity Raises:
- On November 12, 2024, Eaze Inc. announced the closing of a $10M Series B funding following the acquisition of assets from Eaze Technology.
- We have to admit we are somewhat puzzled and need to dig deeper into this story. From an outsider’s point of view, we see Eaze as a company that burned tens of millions on California delivery without ever turning a profit and is now rising from the ashes with a new $10M funding after announcing it was halting operations.
- It gets stranger and stranger: the use of proceeds indicates that the company intends to hire more than 1000 people, double Florida cultivation capacity, open new dispensaries in FL, CA, CO, and MI., and launch new marketing campaigns highlighting Eaze’s newly launched scheduled delivery services.
- Our uniform response to each of these initiatives is, “Really?”
Public vs. Private Raises:
- Two of the week’s three capital raises were public. Both trade in Canada (one on TSX and one on CSE), and both trade in the U.S. on Nasdaq.
Equity vs. Debt Cap Raises:
- Debt accounted for 21,8% of the week’s funds raised.
Week ended 11/15/2024
Additional content is available to Premium and Enterprise users. Please purchase a higher tier membership to see more.
Weekly Valuation Tracker
Viridian highlights a specific industry sector and provides a deep dive into valuation metrics and comparable company valuations for public companies operating in that sector. The Weekly Valuation Tracker provides proprietary, actionable valuation data.
- Week ended 11/15/2024
This week’s valuation tracker focuses on the 7 U.S. MSOs with market cap over $500M in the Viridian Value Tracker database in gauge the valuation impact of the 2nd earnings that have been released so far, Green Thumb (GTII: CSE), Curaleaf (CURA: CSE), and Trulieve.
- Week ended 11/15/2024
This Chart is Only Available to Higher Tier Memberships
Please Purchase a Premium or Enterprise membership to see more.
Additional content is available to Premium and Enterprise users. Please purchase a higher tier membership to see more.
This Chart is Only Available to Higher Tier Memberships
Please Purchase a Premium or Enterprise membership to see more.
Viridian publishes weekly insights on equity capital raises in the Cannabis/CBD/Psychedelic industries. These insights typically highlight the most interesting/meaningful equity transactions of that week, and commentary on market conditions, equity deal structures and investor groups.